Anizatrectinib
Anizatrectinib (hTrkA-IN-1) is a potent and orally active inhibitor of TrkA kinase with an IC50 of 1.3 nM, compound 2 extracted from patent WO2015175788. Anizatrectinib can be used for the study of inflammatory disease, such as prostatitis, pelvic, et al.
For research use only. We do not sell to patients.
- CAS No.: 1824664-89-2
- Formula: C29H32FN7O2
- Molecular Weight:529.61
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
TrkA |
Chemical Information
-
CAS No. 1824664-89-2
-
Molecular Weight 529.61
-
Formula C29H32FN7O2
-
SMILES
O=C(NC1=C(C)C(C2=CN=C(C)N=C2)=NN1C3=CC=CC=C3)N[C@@H]4CN(CCOC)C[C@H]4C5=CC=CC(F)=C5
-
Synonyms
hTrkA-IN-1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)